Each Hour Counts: Improving Management of CRE’s and Other Antibiotic-Resistant BSI’s with Rapid Molecular Diagnostics
Traditional diagnostics for bloodstream infections can take 2-4 days, forcing clinicians to treat suspected bloodstream infections empirically with potentially harmful and unnecessary broad-spectrum antibiotics while awaiting blood culture results. To confound matters, the treatment of serious bacterial infections in clinical practice is often complicated by antibiotic resistance. Resistance rates are increasing among several problematic gram-negative bacilli that are often responsible for serious nosocomial infections, including Acinetobacter spp., Pseudomonas aeruginosa, and Klebsiella spp. The increase in adoption of rapid sepsis diagnostic tests has been driven, in large part, by clinical studies that have captured the clinical and economic impact of these tests. This webinar will look at a few of these studies and discuss the design, execution and clinical and/or economic outcomes achieved in each.